Patent details

301026 Product Name: secukinumab

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
301026
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP2784084
Status:
Withdrawn
Application number:
301026
Procedural language:
Dutch
First Applicant Residence Country:
United States of America (US)

Marketing Authorization

Marketing Authorization Number:
EU/1/14/980
Marketing Authorization Type:
EEA
Marketing Authorization Date:
19/01/2015
Marketing Authorization Country:
European Union (EU)

Dates

Filing date:
09/01/2020
First Marketing Authorization date:
19/01/2015
Grant date:
Activation date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
20/01/2020
SPC/SPC Extension Expiration Date:
01/06/2029
Lapsed By Expiration Date:
Withdrawal date:
29/04/2020
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:

Applicant/holder

From:
09/01/2020
 
 

 

Name:
Genentech, Inc.
Address:
1 DNA Way, SOUTH SAN FRANCISCO, CA 94080-4990, United States of America (US)

Agent

Name:
ir. H.A. Witmans c.s.
From:
09/01/2020
Address:
V.O. Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)
To:

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
20/20
Publication date:
13/05/2020
Description:
Lapse or annulment

2

Bulletin Heading:
SPC
Journal edition number:
04/20
Publication date:
22/01/2020
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Filing date Document type Document Description Number of pages File Type
08/05/2020 Outgoing Correspondence Letter confirmation withdrawal 1 PDF /8/6/5/8/0/0800508568/docs/301026_8_343311l193.pdf
29/04/2020 SPC Documents Mail SPC 2 PDF /8/6/5/8/0/0800508568/docs/301026_6_supplprotectioncertificate20200430011038276.pdf
22/01/2020 Outgoing Correspondence Confirmation receipt request 1 PDF /8/6/5/8/0/0800508568/docs/301026_9_321418l174.pdf
09/01/2020 SPC Documents Marketing Authorization SPC 3 PDF /8/6/5/8/0/0800508568/docs/301026_0_supplprotectioncertificate20200120023646135.pdf
09/01/2020 SPC Documents Annex SPC 41 PDF /8/6/5/8/0/0800508568/docs/301026_1_supplprotectioncertificate20200120023646446.pdf
09/01/2020 SPC Documents Annex SPC 3 PDF /8/6/5/8/0/0800508568/docs/301026_2_supplprotectioncertificate20200120023646377.pdf
09/01/2020 SPC Documents Annex SPC 2 PDF /8/6/5/8/0/0800508568/docs/301026_3_supplprotectioncertificate20200120023646214.pdf
09/01/2020 Incoming Correspondence Paper Accompanying letter incoming document 2 PDF /8/6/5/8/0/0800508568/docs/301026_4_incomingcorrespondencepaper20200120023646069.pdf
09/01/2020 SPC Documents Summary of the characteristics of the product 40 PDF /8/6/5/8/0/0800508568/docs/301026_5_supplprotectioncertificate20200120023646305.pdf
09/01/2020 Payment Order Dossier Payment Order 1 PDF /8/6/5/8/0/0800508568/docs/301026_7_paymentorderdossier20200120023645994.pdf
09/01/2020 Application Form First filed application form 3 PDF /8/6/5/8/0/0800508568/docs/301026_10_applicationform20200120023645907.pdf